NasdaqCM - Nasdaq Real Time Price ? USD TuHURA Biosciences, Inc. (HURA) Follow Compare 5.27 +0.29 (+5.82%) At close: November 6 at 4:00 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations TuHURA Biosciences (Nasdaq: HURA) Announces Webcast Replay of Panel Presentation at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC TAMPA, FL / ACCESSWIRE / October 23, 2024 / TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 registration-stage immune-oncology company developing novel technologies to overcome resistance to cancer immunotherapy, today ... ACCESSWIRE ? 15 days ago HURA +5.82% TuHURA Biosciences (NASDAQ:HURA) to Present at the Virtual Investor "New to the Street" Event Live moderated webcast with Dr. Jim Bianco, President and Chief Executive Officer of TuHURA on Wednesday, October 30th at 4 PM ET TAMPA, FL / ACCESSWIRE / October 22, 2024 / TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase ... ACCESSWIRE ? 15 days ago HURA +5.82% TuHURA Biosciences Completes Merger Transaction with Kintara Therapeutics Combined company will operate as TuHURA Biosciences, Inc. and advance pipeline of novel technologies to overcome resistance to cancer immunotherapy Lead program entering single Phase 3 accelerated approval registration trial in first half of 2025 ... ACCESSWIRE ? 20 days ago HURA +5.82% Performance Overview Trailing total returns as of 11/6/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return HURA S&P 500 YTD -11.43% +24.30% 1-Year -65.78% +36.04% 3-Year -99.68% +26.22%
